Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s What Happened

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up before the market opened on Thursday . The stock had previously closed at $3.8270, but opened at $4.10. Curaleaf shares last traded at $3.44, with a volume of 652,820 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Curaleaf currently has an average rating of “Buy”.

Curaleaf Stock Down 13.5%

The firm has a market cap of $2.28 billion, a P/E ratio of -11.03 and a beta of 0.77. The stock’s 50 day simple moving average is $2.40 and its 200 day simple moving average is $2.59. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.76 and a current ratio of 1.52.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $333.07 million during the quarter, compared to analyst estimates of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. Research analysts anticipate that Curaleaf Holdings, Inc. will post -0.28 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.